Peter Malfertheiner Selected Research

Albumins

1/2022	Prognostic value of baseline imaging and clinical features in patients with advanced hepatocellular carcinoma.
6/2021	Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization.
2/2015	Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC.
1/2003	Clinical implications of alpha-fetoprotein expression in gastric adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Malfertheiner Research Topics

Disease

74	Neoplasms (Cancer) 04/2024 - 01/2002
62	Stomach Neoplasms (Stomach Cancer) 03/2024 - 01/2002
56	Infections 01/2024 - 07/2002
36	Gastroesophageal Reflux (GERD) 12/2018 - 01/2004
34	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 01/2006
25	Carcinogenesis 04/2024 - 01/2002
23	Gastritis 03/2024 - 07/2002
15	Inflammation (Inflammations) 07/2023 - 04/2005
15	Adenocarcinoma 01/2022 - 01/2003
13	Atrophic Gastritis 01/2022 - 10/2005
13	Peptic Ulcer (Peptic Ulcers) 01/2021 - 01/2002
13	Ulcer 08/2020 - 01/2002
12	Dyspepsia (Indigestion) 01/2021 - 01/2003
10	Atrophy 01/2022 - 05/2002
10	Metaplasia 01/2022 - 05/2002
10	Neoplasm Metastasis (Metastasis) 12/2020 - 05/2003
10	Hemorrhage 09/2016 - 01/2002
8	Liver Cirrhosis (Hepatic Cirrhosis) 04/2024 - 01/2009
8	Pancreatic Neoplasms (Pancreatic Cancer) 02/2020 - 01/2003
8	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2019 - 07/2002
8	Pathologic Constriction (Stenosis) 01/2016 - 01/2002
8	Heartburn (Pyrosis) 06/2011 - 07/2006
7	Diarrhea 03/2024 - 11/2009
7	Carcinoma (Carcinomatosis) 09/2011 - 08/2002
6	Liver Neoplasms (Liver Cancer) 01/2023 - 01/2006
6	Chronic Pancreatitis 06/2014 - 01/2002
6	Pancreatitis 03/2014 - 04/2002
5	Ascites 01/2023 - 01/2004
5	Fibrosis (Cirrhosis) 12/2021 - 09/2002
5	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 01/2005
5	Crohn Disease (Crohn's Disease) 08/2012 - 07/2002
4	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2024 - 02/2006
4	Liver Diseases (Liver Disease) 06/2021 - 01/2008
4	Hepatic Encephalopathy 01/2019 - 07/2014
4	Esophagitis 12/2018 - 12/2007
4	Chronic Hepatitis C 11/2017 - 07/2005
4	Disease Progression 02/2016 - 02/2003
4	Weight Loss (Weight Reduction) 03/2014 - 01/2009
4	Ulcerative Colitis 08/2012 - 04/2005
4	Colitis 08/2012 - 10/2004
4	Pain (Aches) 05/2006 - 01/2003
3	Peritonitis 01/2023 - 06/2006
3	Barrett Esophagus (Barrett's Esophagus) 02/2018 - 01/2008
3	Hyperplasia 12/2017 - 09/2010
3	Colonic Neoplasms (Colon Cancer) 09/2014 - 01/2005

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 07/2023 - 01/2002
24	Biomarkers (Surrogate Marker)IBA 04/2024 - 09/2002
20	AcidsIBA 03/2021 - 05/2006
19	Sorafenib (BAY 43-9006)FDA Link 04/2024 - 01/2011
17	Proton Pump InhibitorsIBA 01/2021 - 01/2003
15	MicroRNAs (MicroRNA)IBA 04/2024 - 01/2012
13	Anti-Bacterial Agents (Antibiotics)IBA 07/2023 - 01/2003
11	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2021 - 01/2002
10	Messenger RNA (mRNA)IBA 07/2017 - 01/2002
9	Interleukin-8 (Interleukin 8)IBA 06/2021 - 05/2004
9	EnzymesIBA 02/2015 - 04/2005
8	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 01/2002
8	CytokinesIBA 01/2018 - 04/2005
7	AntigensIBA 07/2023 - 09/2008
7	Pepsinogen A (Pepsinogen)IBA 12/2019 - 01/2011
6	AntibodiesIBA 12/2021 - 02/2006
6	AntralIBA 01/2011 - 04/2004
5	Clarithromycin (Biaxin)FDA LinkGeneric 01/2023 - 01/2009
5	SirtuinsIBA 09/2022 - 12/2020
5	Metronidazole (Metric)FDA LinkGeneric 01/2022 - 04/2004
5	BilirubinIBA 01/2022 - 06/2014
5	DNA (Deoxyribonucleic Acid)IBA 10/2019 - 12/2005
5	Esomeprazole (Nexium)FDA Link 01/2013 - 12/2005
5	ProteomeIBA 09/2006 - 09/2004
4	Capsules (Microcapsules)IBA 11/2023 - 03/2011
4	AlbuminsIBA 01/2022 - 01/2003
4	Urea (Carbamide)FDA LinkGeneric 01/2021 - 01/2003
4	Gemcitabine FDA Link 02/2020 - 02/2006
4	Cytotoxins (Cytolysins)IBA 10/2018 - 09/2008
4	Peptide Hydrolases (Proteases)FDA Link 01/2018 - 09/2010
4	Blood Proteins (Serum Proteins)IBA 12/2017 - 11/2004
4	UreaseIBA 10/2011 - 10/2006
4	Secretory Leukocyte Peptidase InhibitorIBA 02/2009 - 04/2004
3	CarcinogensIBA 11/2023 - 08/2008
3	Fluorouracil (Carac)FDA LinkGeneric 01/2022 - 04/2010
3	BismuthIBA 01/2021 - 10/2010
3	VaccinesIBA 10/2018 - 09/2008
3	RamucirumabIBA 01/2018 - 01/2017
3	Virulence Factors (Pathogenicity Factors)IBA 12/2014 - 01/2011
3	Transcription Factors (Transcription Factor)IBA 01/2014 - 06/2005
3	AutoantibodiesIBA 01/2013 - 04/2011
3	Cathepsin WIBA 12/2011 - 07/2002
3	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2011 - 04/2005
3	Omeprazole (Prilosec)FDA LinkGeneric 03/2011 - 01/2003

Therapy/Procedure

83	Therapeutics 03/2024 - 01/2002
9	Drug Therapy (Chemotherapy) 01/2018 - 01/2003
8	Radiotherapy 01/2022 - 01/2003
7	Stents 01/2016 - 11/2003
6	Secondary Prevention 10/2021 - 01/2002
4	Aftercare (After-Treatment) 12/2021 - 08/2005
4	Brachytherapy 02/2019 - 01/2009
4	Gastrectomy 05/2016 - 04/2005
3	Microspheres (Microsphere) 12/2020 - 01/2009
3	Chemoprevention 01/2019 - 09/2005
3	Self Expandable Metallic Stents 01/2016 - 01/2002